Last reviewed · How we verify
High sevoflurane
High sevoflurane is a Small molecule drug developed by Keimyung University Dongsan Medical Center. It is currently in Phase 1 development.
-
Baseline phase 1 → approval rate
+9.6pp
Industry-wide phase 1 drugs reach approval ~9.6% of the time (BIO/Informa 2023 industry benchmark across all therapeutic areas).
| Regulator | Country | Likely year | Lag vs FDA |
|---|---|---|---|
| FDA | US | 2033–2036 | — |
| EMA | EU | 2034–2037 | +0.7 yr |
| MHRA | GB | 2034–2037 | +0.7 yr |
| Health Canada | CA | 2034–2038 | +0.9 yr |
| TGA | AU | 2034–2038 | +1.2 yr |
| PMDA | JP | 2034–2038 | +1.5 yr |
| NMPA | CN | 2035–2039 | +2.3 yr |
| MFDS | KR | 2034–2038 | +1.4 yr |
| CDSCO | IN | 2034–2039 | +1.8 yr |
| ANVISA | BR | 2035–2039 | +2.3 yr |
Hover any row for the lag rationale. Lag estimates are reduced when the drug has FDA Breakthrough or EMA PRIME designation (sponsors file globally in parallel).
Estimate based on the BIO/Informa industry phase transition rates plus per-drug modifiers for therapeutic area, sponsor type, FDA designations, mechanism, and trial design. Per-jurisdiction lags from Tufts CSDD international approval studies. Not investment, clinical or regulatory advice. Methodology: /methodology#likelihood.
At a glance
| Generic name | High sevoflurane |
|---|---|
| Sponsor | Keimyung University Dongsan Medical Center |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- Headache
- Hypotension
- Nausea
- Vomiting
- Postoperative CT-scan
- Tachycardia
- Drug reaction
- Reflex syncope
- Bradycardia
- Chills
- Gastrooesophageal reflux disease
- Oropharyngeal pain
Key clinical trials
- The Effect of the Anticholinergic Burden Following Elective Coronary Artery Surgery (PHASE4)
- Effects of an Opioid Free/Sparing Care Pathway for Patients Undergoing Obesity Surgery (NA)
- Optic Nerve Sheath Diameter and Postoperative Cognitive Disfunction at Laparoscopic Surgery
- Going to Altitude With Anxious-depressive Symptoms (NA)
- Efficacy of Magnesium Sulfate as an Adjuvant in Erector Spinae Plane Block as an Anesthetic Post Operative After Modified Radical Mastectomy (EARLY_PHASE1)
- Minimal Flow Anesthesia and Infection Risk (NA)
- Muscle Relaxation for Pediatric Adenotonsillectomy (PHASE4)
- Non-opioid Anesthesia Based on Thoracic Paravertebral Block During Laparoscopic Sleeve Gastrectomy (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- High sevoflurane CI brief — competitive landscape report
- High sevoflurane updates RSS · CI watch RSS
- Keimyung University Dongsan Medical Center portfolio CI
Frequently asked questions about High sevoflurane
What is High sevoflurane?
Who makes High sevoflurane?
What development phase is High sevoflurane in?
What are the side effects of High sevoflurane?
Related
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing